annual cash & cash equivalents:
$89.14M+$29.06M(+48.36%)Summary
- As of today (June 19, 2025), RYTM annual cash & cash equivalents is $89.14 million, with the most recent change of +$29.06 million (+48.36%) on December 31, 2024.
- During the last 3 years, RYTM annual cash & cash equivalents has risen by +$29.89 million (+50.45%).
- RYTM annual cash & cash equivalents is now -30.19% below its all-time high of $127.68 million, reached on December 31, 2022.
Performance
RYTM Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$106.09M+$16.96M(+19.02%)Summary
- As of today (June 19, 2025), RYTM quarterly cash & cash equivalents is $106.09 million, with the most recent change of +$16.96 million (+19.02%) on March 31, 2025.
- Over the past year, RYTM quarterly cash & cash equivalents has increased by +$52.67 million (+98.58%).
- RYTM quarterly cash & cash equivalents is now -49.59% below its all-time high of $210.48 million, reached on June 30, 2018.
Performance
RYTM quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RYTM Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.4% | +98.6% |
| 3 y3 years | +50.5% | +35.1% |
| 5 y5 years | +43.1% | +90.2% |
RYTM Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.2% | +50.5% | -42.7% | +123.3% |
| 5 y | 5-year | -30.2% | +50.5% | -42.7% | +123.3% |
| alltime | all time | -30.2% | +1263.0% | -49.6% | +1522.3% |
RYTM Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $106.09M(+19.0%) |
| Dec 2024 | $89.14M(+48.4%) | $89.14M(+87.6%) |
| Sep 2024 | - | $47.52M(-70.6%) |
| Jun 2024 | - | $161.67M(+202.6%) |
| Mar 2024 | - | $53.43M(-11.1%) |
| Dec 2023 | $60.08M(-52.9%) | $60.08M(-7.0%) |
| Sep 2023 | - | $64.59M(-44.2%) |
| Jun 2023 | - | $115.68M(+5.5%) |
| Mar 2023 | - | $109.66M(-14.1%) |
| Dec 2022 | $127.68M(+115.5%) | $127.68M(-31.0%) |
| Sep 2022 | - | $185.09M(+63.5%) |
| Jun 2022 | - | $113.21M(+44.1%) |
| Mar 2022 | - | $78.54M(+32.6%) |
| Dec 2021 | $59.25M(-41.3%) | $59.25M(-35.9%) |
| Sep 2021 | - | $92.37M(+33.2%) |
| Jun 2021 | - | $69.34M(-20.5%) |
| Mar 2021 | - | $87.27M(-13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $100.85M(+61.9%) | $100.85M(+49.0%) |
| Sep 2020 | - | $67.67M(+14.5%) |
| Jun 2020 | - | $59.09M(+5.9%) |
| Mar 2020 | - | $55.78M(-10.5%) |
| Dec 2019 | $62.29M(+25.7%) | $62.29M(-13.1%) |
| Sep 2019 | - | $71.68M(+13.6%) |
| Jun 2019 | - | $63.12M(+50.2%) |
| Mar 2019 | - | $42.02M(-15.2%) |
| Dec 2018 | $49.54M(+44.7%) | $49.54M(-14.9%) |
| Sep 2018 | - | $58.25M(-72.3%) |
| Jun 2018 | - | $210.48M(+387.6%) |
| Mar 2018 | - | $43.17M(+26.1%) |
| Dec 2017 | $34.24M(+423.5%) | $34.24M(+22.6%) |
| Sep 2017 | - | $27.91M(-4.4%) |
| Jun 2017 | - | $29.20M(+346.5%) |
| Dec 2016 | $6.54M(-81.2%) | $6.54M |
| Dec 2015 | $34.87M | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Rhythm Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of RYTM is $89.14M
What is the all time high annual cash & cash equivalents for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash & cash equivalents is $127.68M
What is Rhythm Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, RYTM annual cash & cash equivalents has changed by +$29.06M (+48.36%)
What is Rhythm Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RYTM is $106.09M
What is the all time high quarterly cash & cash equivalents for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash & cash equivalents is $210.48M
What is Rhythm Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, RYTM quarterly cash & cash equivalents has changed by +$52.67M (+98.58%)